Imatinib Terminated Phase 1 / 2 Trials for Prostatic Neoplasms / Prostate Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs